Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain

NCT00313820 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Neuropathic Pain

Interventions

DRUG: Pregabalin
DRUG: Placebo

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.